Asston Pharmaceuticals Limited
Asston Pharmaceuticals Limited is a Private Indian company incorporated in 2019 and based in Maharashtra, India. Asston Pharmaceuticals Limited operates in Pharmaceuticals & Chemicals (NIC 24304) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
ASSTON PHARMACEUTICALS LIMITED is the legal entity of ASSTON PHARMACEUTICALS.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Asston Pharmaceuticals Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +37d | filed |
| MGT-7 | FY2024-25 | 27 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +10d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 20 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Asston Pharmaceuticals Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 910083222 | State Bank of India(Bank) | ₹11.99 Cr | 19 Sep 2022 | Satisfied |
| 279060181 | State Bank of India(Bank) | ₹22.52 Cr | 12 Mar 2020 | Open |
| 415406699 | State Bank of India(Bank) | ₹10.14 Cr | 19 Sep 2021 | Open |
| 404123831 | HDFC Bank Ltd(Bank) | ₹20.92 Cr | 27 Jan 2021 | Open |
Charge IDs, lenders & amounts for Asston Pharmaceuticals Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹7.73 Cr | ₹-54.69 L | ₹4.32 Cr | ₹10.98 Cr | 269 |
| FY2023-24 | ₹6.85 Cr | ₹-34.04 L | ₹3.80 Cr | ₹8.09 Cr | 348 |
| FY2022-23 | ₹6.77 Cr | ₹-38.00 L | ₹4.15 Cr | ₹7.61 Cr | 19 |
| FY2021-22 | ₹6.10 Cr | ₹-26.85 L | ₹6.18 Cr | ₹9.38 Cr | 148 |
Audited financials & ratios for Asston Pharmaceuticals Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹7.73 Cr | ₹6.85 Cr | ₹6.77 Cr | ₹6.10 Cr |
| Other income | ₹4.80 L | ₹13.76 L | ₹11.56 L | ₹14.22 L |
| Total income | ₹7.78 Cr | ₹6.99 Cr | ₹6.88 Cr | ₹6.24 Cr |
| Total expenses | ₹8.48 Cr | ₹7.43 Cr | ₹7.37 Cr | ₹6.58 Cr |
| Profit before tax | ₹-71.09 L | ₹-44.25 L | ₹-49.40 L | ₹-34.91 L |
| Profit / (Loss) after tax | ₹-54.69 L | ₹-34.04 L | ₹-38.00 L | ₹-26.85 L |
| Balance sheet | ||||
| Equity / Net worth | ₹4.32 Cr | ₹3.80 Cr | ₹4.15 Cr | ₹6.18 Cr |
| Borrowings | ₹2.47 Cr | ₹1.47 Cr | ₹1.27 Cr | ₹1.09 Cr |
| Current liabilities | ₹3.43 Cr | ₹1.44 Cr | ₹1.97 Cr | ₹1.37 Cr |
| Total liabilities | ₹6.66 Cr | ₹4.29 Cr | ₹3.45 Cr | ₹3.21 Cr |
| Current assets | ₹5.41 Cr | ₹3.44 Cr | ₹2.86 Cr | ₹4.61 Cr |
| Cash & equivalents | ₹1.16 Cr | ₹1.10 Cr | ₹76.14 L | ₹55.91 L |
| Total assets | ₹10.98 Cr | ₹8.09 Cr | ₹7.61 Cr | ₹9.38 Cr |
| Employees | 269 | 348 | 19 | 148 |
Audited financials & ratios for Asston Pharmaceuticals Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹7.73 Cr | +21.9% | +23.5% | +8.4% |
| Profit after Tax | ₹-54.69 L | +13.4% | +21.0% | +14.2% |
| Net Worth | ₹4.32 Cr | -2.7% | +4.7% | +14.0% |
| Employees | 269 | +23.6% | +26.1% | +2.7% |
Audited financials & ratios for Asston Pharmaceuticals Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹7.73 Cr | ₹-54.69 L | -7.07% | -6.58% | -12.66% | -4.98% | 0.57 | ₹2.87 L |
| FY2023-24 | ₹6.85 Cr | ₹-34.04 L | -4.97% | -5.66% | -8.97% | -4.21% | 0.39 | ₹1.97 L |
| FY2022-23 | ₹6.77 Cr | ₹-38.00 L | -5.61% | +9.50% | -9.15% | -5.00% | 0.31 | ₹35.62 L |
| FY2021-22 | ₹6.10 Cr | ₹-26.85 L | -4.40% | +1.57% | -4.35% | -2.86% | 0.18 | ₹4.12 L |
Audited financials & ratios for Asston Pharmaceuticals Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 1,41,37,527 | 69.93% |
| Institutional Investors | 3 | 19,10,503 | 9.45% |
| Public & Others | 22 | 41,67,530 | 20.62% |
Promoter, institutional & public holding for Asston Pharmaceuticals Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
374 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.